Skip to news
JQJO
Latest

Flu Vaccine Shows Effectiveness Despite A(H3N2) Variants | JQJO

Flu Vaccine Shows Effectiveness Despite A(H3N2) Variants

Flu Vaccine Shows Effectiveness Despite A(H3N2) Variants

Tap title to read story

0:00 / 0:00

Interim estimates show the 2024-25 influenza vaccine was effective in preventing influenza-related illness in the US, with varying efficacy (32-78%) across age groups and settings. While effectiveness against A(H3N2) was lower and similar to previous years, the overall findings are consistent with Canada and South America. Despite limitations like preliminary data and potential misclassification, the CDC emphasizes vaccination as crucial for preventing influenza and associated hospitalizations, recommending vaccination for all those aged 6 months and older.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Willie Geist Leaves Morning Joe

Tap title to read story

0:00 / 0:30

Musk Urges Nvidia to Rehire Huang

Tap title to read story

0:00 / 0:44

Glenn Close, Ridley Scott Honored

Tap title to read story

0:00 / 0:41

JQJO

Find your next story

Search JQJO’s current coverage.